a(CHEBI:cilostazol) increases p(FPLX:AMPK, pmod(Ph, Tyr, 172))

View Subject View Object

PubMed:30116051

Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .

Related Edges 8

• a(CHEBI:cilostazol) decreases a(CHEBI:"amyloid-beta polypeptide 42")
• a(CHEBI:cilostazol) increases bp(GO:macroautophagy)
• a(CHEBI:cilostazol) increases p(HGNC:BECN1)
• a(CHEBI:cilostazol) increases p(HGNC:ATG5)
• a(CHEBI:cilostazol) increases p(HGNC:MAP1LC3A)
• a(CHEBI:cilostazol) decreases p(FPLX:mTORC1)
• a(CHEBI:cilostazol) increases p(HGNC:CTSB)
• a(CHEBI:cilostazol) increases act(p(HGNC:SIRT1))

MeSH

Machado-Joseph Disease

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.

---